Brent Hatzis-Schoch, See Remarks at Black Diamond Therapeutics, Inc. (BDTX), sold 7,849 shares at $27.19 ($214K) on 2021-02-12, disclosed to the SEC on 2021-02-12.
Open-market sale of $214k BDTX by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.19 | 3,771 | $103K | 48.0% |
| 2 | $27.19 | 3,771 | $103K | 48.0% |
| 3 | $27.66 | 307 | $8K | 4.0% |
| Total | $27.21 avg | 7,849 | $214K | 100% |
| Filing → |
| BDTX | SELL | 2021-03-16 | $215K | — | Filing → |
| BDTX | SELL | 2021-01-14 | $506K | — | Filing → |
| BDTX | SELL | 2020-12-16 | $285K | — | Filing → |